AVR anteris technologies global corp.

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-31

  1. 6,439 Posts.
    lightbulb Created with Sketch. 42
    "You're new to biotechs"
    bout as new as you are to them
    pig headiness stopped them from a deal like this
    I've had it out with them many times over the years to let others sell for them but their wisdom was to run the coy into the ground till they had no choice. if done early do you think the deal would have been a lot better? I know i do and shareholders like yourself would have made some ???
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.89
Change
-0.290(5.60%)
Mkt cap ! $75.81M
Open High Low Value Volume
$5.15 $5.15 $4.88 $45.35K 9.049K

Buyers (Bids)

No. Vol. Price($)
1 200 $4.98
 

Sellers (Offers)

Price($) Vol. No.
$5.08 570 2
View Market Depth
Last trade - 12.06pm 21/07/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.